Myocardial Infarction News and Research

RSS

Study suggests limiting oral corticosteroid use to 90 days reduces adverse effects in atopic dermatitis patients

Researchers evaluated the association between long-term oral corticosteroid use and adverse events in adult patients with atopic dermatitis.

24 Jul 2024

Beyond the anti-obesity benefits of glucagon-like peptide-1 drugs

The advantages of glucagon-like peptide-1 (GLP-1) medicines beyond glycemic and weight control.

23 Jul 2024

American Heart Association recognizes 3147 organizations for commitment to improving cardiovascular care

Someone in the United States dies of cardiovascular disease (CVD) every 34 seconds, on average. Reducing deaths from CVD requires a coordinated approach to care and a commitment to following science-based treatment guidelines.

17 Jul 2024

Four years non-diabetic status after impaired glucose tolerance diagnosis cuts cardiovascular risks

Maintaining non-diabetic status for at least four years after impaired glucose tolerance diagnosis significantly lowers the risk of cardiovascular complications and mortality.

10 Jul 2024

Combined use of popular diabetes drugs likely to offer additional protection against heart and kidney disease

New research shows combined use of sodium glucose co-transporter 2 inhibitors (SGLT2is) and glucagon-like peptide-1 receptor agonists (GLP1-RAs) is likely to offer additional protection against heart and kidney disease in patients with diabetes.

8 Jul 2024

Nonimaging self-report tool effectively predicts coronary atherosclerosis

Researchers assessed whether non-imaging data could be used to identify people with coronary atherosclerosis.

8 Jul 2024

Neuromuscular training reduces chemotherapy-induced neuropathy and improves patient outcomes

Researchers found that neuromuscular training significantly reduces the incidence and severity of chemotherapy-induced peripheral neuropathy, improving patient quality of life and treatment outcomes.

7 Jul 2024

Study of healthy adults over 20+ years reveals daily multivitamin use is not associated with mortality benefit

A recent study published in JAMA Network Open determined the relationship between regular multivitamin (MV) supplementation and mortality risk among United States adults.

28 Jun 2024

Study finds lower cancer risk with alcohol abstinence and rehabilitation

A new study conducted by the Centre for Addiction and Mental Health (CAMH), Bordeaux University Hospital, France, and the World Health Organization (WHO) has found that individuals with alcohol dependence who undergo rehabilitation or maintain abstinence experience significantly lower risks of developing alcohol-associated cancers.

26 Jun 2024

Plant-based meat substitutes show promise for heart health

Even though there is substantial variability in the contents and nutritional profiles of plant-based meat alternatives (PBMAs), the nutritional profiles tend to reflect a heart-healthy dietary pattern.

26 Jun 2024

Semaglutide proves a game-changer for kidney and heart health in diabetes patients

The FLOW trial demonstrated that semaglutide significantly improves kidney and cardiovascular outcomes in people with chronic kidney disease and type 2 diabetes, irrespective of SGLT2 inhibitor use.

25 Jun 2024

Study reveals high rates of aspirin use for CVD prevention among older adults

A survey representing about 150 million adults annually suggests that aspirin use for primary prevention of cardiovascular disease (CVD) remains prevalent among older adults, contrary to recommendations from the American College of Cardiology and the American Heart Association.

24 Jun 2024

Novo Nordisk presents key findings from semaglutide trials at ADA scientific sessions 2024

Novo Nordisk today announced the presentation of 34 abstracts highlighting the breadth of its portfolio at the upcoming 84th Scientific Sessions of the American Diabetes Association (ADA).

22 Jun 2024

Safety-focused summary of GLP-1 receptor agonists in diabetes, obesity, and beyond

A recent review in Diabetes Care evaluates the efficacy and safety of GLP-1 receptor agonists for type 2 diabetes and obesity, exploring their potential for new medical indications.

18 Jun 2024

Waist-to-height ratio surpasses conventional metrics in predicting cardiovascular disease risk

Research shows waist-to-height ratio (WHtR) outperforms body fat percentage (BF%) and other central obesity measures in predicting ischemic cardiovascular disease (CVD) risk.

12 Jun 2024

Study reveals a key step to help the heart regenerate after myocardial infarction

A new study by investigators at Massachusetts General Hospital (MGH), a founding member of the Mass General Brigham (MGB) healthcare system, reveals an important step to help the human heart regenerate after myocardial infarction (MI).

10 Jun 2024

Vigorous exercise linked to lower dementia risk in hypertensive individuals

The effect of vigorous physical activity (VPA) on the risk of incident mild cognitive impairment (MCI) and probable dementia.

10 Jun 2024

Novel insights into the underlying, contributing, and direct causes of death in Australia

Coronary heart disease (CHD) was involved in 1 in 5 deaths in 2022 when using all of the information included on the medical death certificate, according to a new Australian Institute of Health and Welfare (AIHW) release revealing what Australians are most likely to die from.

8 Jun 2024

Moderate choline intake lowers heart disease risk

A recent study from BMC Public Health found that moderate dietary choline intake is associated with a reduced risk of atherosclerotic cardiovascular disease (ASCVD) among US adults.

4 Jun 2024

Studies underscore the relationship between narcolepsy and cardiovascular disease

Two new studies to be presented at the SLEEP 2024 annual meeting show that narcolepsy is an independent risk factor for cardiovascular disease and adverse cardiac events.